Table 2. Antibiotic susceptibility profile of clinical vancomycin resistant Enterococci (VRE) isolates from Caribbean countries, 2009–2014 (%).
| Antimicrobial agent | E. faecium | E. faecalis | ||
|---|---|---|---|---|
| Sensitive | Resistant | Sensitive | Resistant | |
| Ampicillin | 5 (7.1) | 65 (92.8) | 0 | 7 (100) |
| Chloramphenicol | 15 (21.4 | 55 (78.6) | 2 (28.6) | 5 (71.4) |
| Ciprofloxacin | 0 | 70 (100) | 0 | 7 (100) |
| Daptomycin | 70 (100) | 0 | 7 (100) | 0 |
| Erythromycin | 0 | 70 (100) | 0 | 7 (100) |
| Gentamicin | 65 (92.8) | 5 (7.2) | 4 (57.1) | 3 (42.9) |
| Levofloxacin | 5 (7.1) | 65 (92.9) | 0 | 7 (100) |
| Linezolid | 70 (100) | 0 | 7 (100) | 0 |
| Penicillin | 0 | 70 (100) | 0 | 7 (100) |
| Quinuprustin/Dalfopristin | 70 (100) | 0 | 7 (100) | 0 |
| Streptomycin | 45 (64.3) | 25 (35.7) | 5 (71.4) | 2 (28.6) |
| Tetracycline | 25 (35.7) | 45 (64.3) | 0 | 7 (100) |
| Teicoplanin | 70 (100) | 0 | 7 (100) | 0 |
| Tigecycline | 70 (100) | 0 | 7 (100) | 0 |
| Vancomycin | 0 | 70 (100) | 0 | 7 (100) |